Yüklüyor......
EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
Molecular genetic testing for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is offered worldwide and is of importance for differential diagnosis, carrier detection and adequate genetic counseling, particularly for family planning. In 2008 the European Molecular Genet...
Kaydedildi:
| Yayımlandı: | Eur J Hum Genet |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609334/ https://ncbi.nlm.nih.gov/pubmed/32616876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41431-020-0653-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|